Amyloid-β aggregates activate peripheral monocytes in mild cognitive impairment

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Amyloid-β aggregates activate peripheral monocytes in mild cognitive impairment ; volume:15 ; number:1 ; day:9 ; month:2 ; year:2024 ; pages:1-20 ; date:12.2024
Nature Communications ; 15, Heft 1 (9.2.2024), 1-20, 12.2024

Classification: Sozialwissenschaften, Soziologie, Anthropologie

Creator: Juul-Madsen, Kristian
Parbo, Peter
Ismail, Rola
Ovesen, Peter L.
Schmidt, Vanessa
Madsen, Lasse S.
Thyrsted, Jacob
Gierl, Sarah
Breum, Mihaela
Larsen, Agnete
Andersen, Morten N.
Romero-Ramos, Marina
Holm, Christian K.
Andersen, Gregers R.
Zhao, Huaying
Schuck, Peter
Nygaard, Jens V.
Sutherland, Duncan S.
Eskildsen, Simon F.
Willnow, Thomas E.
Brooks, David J.
Vorup-Jensen, Thomas

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41467-024-45627-y

URN: urn:nbn:de:101:1-2404180712592.787438788033

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:48 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Juul-Madsen, Kristian
Parbo, Peter
Ismail, Rola
Ovesen, Peter L.
Schmidt, Vanessa
Madsen, Lasse S.
Thyrsted, Jacob
Gierl, Sarah
Breum, Mihaela
Larsen, Agnete
Andersen, Morten N.
Romero-Ramos, Marina
Holm, Christian K.
Andersen, Gregers R.
Zhao, Huaying
Schuck, Peter
Nygaard, Jens V.
Sutherland, Duncan S.
Eskildsen, Simon F.
Willnow, Thomas E.
Brooks, David J.
Vorup-Jensen, Thomas
SpringerLink (Online service)

Other Objects (12)

Amyloid-β 1–24 C-terminal truncated fragment promotes amyloid-β 1–42 aggregate formation in the healthy brain

Soluble aggregates of the amyloid-β peptide are trapped by serum albumin to enhance amyloid-β activation of endothelial cells

Origins of amyloid-β

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Selective amyloid-β lowering agents

Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates

Identification of proteins that specifically recognize and bind protofibrillar aggregates of amyloid-β

EGCG directly targets intracellular amyloid-β(1-42) aggregates and promotes their lysosomal degradation

Hochschulschrift

Development of conformation specific Amyloid-β [Amyloid-beta] antibodies

Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery

The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro

Copper mediated amyloid-β binding to Transthyretin

Amyloid-β 1–24 C-terminal truncated fragment promotes amyloid-β 1–42 aggregate formation in the healthy brain

Soluble aggregates of the amyloid-β peptide are trapped by serum albumin to enhance amyloid-β activation of endothelial cells

Origins of amyloid-β

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Selective amyloid-β lowering agents

Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates

Identification of proteins that specifically recognize and bind protofibrillar aggregates of amyloid-β

EGCG directly targets intracellular amyloid-β(1-42) aggregates and promotes their lysosomal degradation

Hochschulschrift

Development of conformation specific Amyloid-β [Amyloid-beta] antibodies

Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery

The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro

Copper mediated amyloid-β binding to Transthyretin

Amyloid-β 1–24 C-terminal truncated fragment promotes amyloid-β 1–42 aggregate formation in the healthy brain

Soluble aggregates of the amyloid-β peptide are trapped by serum albumin to enhance amyloid-β activation of endothelial cells

Origins of amyloid-β

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Selective amyloid-β lowering agents

Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates

Identification of proteins that specifically recognize and bind protofibrillar aggregates of amyloid-β

EGCG directly targets intracellular amyloid-β(1-42) aggregates and promotes their lysosomal degradation

Hochschulschrift

Development of conformation specific Amyloid-β [Amyloid-beta] antibodies

Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery

The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro

Copper mediated amyloid-β binding to Transthyretin

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Amyloid-β aggregates activate peripheral monocytes in mild cognitive impairment

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Amyloid-β 1–24 C-terminal truncated fragment promotes amyloid-β 1–42 aggregate formation in the healthy brain

Soluble aggregates of the amyloid-β peptide are trapped by serum albumin to enhance amyloid-β activation of endothelial cells

Origins of amyloid-β

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Selective amyloid-β lowering agents

Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates

Identification of proteins that specifically recognize and bind protofibrillar aggregates of amyloid-β

EGCG directly targets intracellular amyloid-β(1-42) aggregates and promotes their lysosomal degradation

Development of conformation specific Amyloid-β [Amyloid-beta] antibodies

Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery

The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro

Copper mediated amyloid-β binding to Transthyretin

Amyloid-β 1–24 C-terminal truncated fragment promotes amyloid-β 1–42 aggregate formation in the healthy brain

Soluble aggregates of the amyloid-β peptide are trapped by serum albumin to enhance amyloid-β activation of endothelial cells

Origins of amyloid-β

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Selective amyloid-β lowering agents

Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates

Identification of proteins that specifically recognize and bind protofibrillar aggregates of amyloid-β

EGCG directly targets intracellular amyloid-β(1-42) aggregates and promotes their lysosomal degradation

Development of conformation specific Amyloid-β [Amyloid-beta] antibodies

Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery

The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro

Copper mediated amyloid-β binding to Transthyretin

Amyloid-β 1–24 C-terminal truncated fragment promotes amyloid-β 1–42 aggregate formation in the healthy brain

Soluble aggregates of the amyloid-β peptide are trapped by serum albumin to enhance amyloid-β activation of endothelial cells

Origins of amyloid-β

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Selective amyloid-β lowering agents

Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates

Identification of proteins that specifically recognize and bind protofibrillar aggregates of amyloid-β

EGCG directly targets intracellular amyloid-β(1-42) aggregates and promotes their lysosomal degradation

Development of conformation specific Amyloid-β [Amyloid-beta] antibodies

Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery

The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro

Copper mediated amyloid-β binding to Transthyretin

Related objects

Reset password